Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy for acute ischemic stroke: Emergency management of stroke (EMS) bridging trial
Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy for acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 1999;30:2598-2605
EMS Bridging Trial - Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset
Derex L, Tomsick TA, Brott TG, et al. EMS Bridging Trial - Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. AJNR Am J Neuroradiol 2001;22:685-690
PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11
Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial
Adam HP, Bendixen BH, Kapelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41